John Dennis, PhD

President and CEO & Head of Drug Delivery

John is a respiratory drug aerosol device and delivery specialist authoring over 100 medical aerosol technology publications and is the strategic leader of SolAeroMed. His business expertise was developed through a separate consultancy dealing with aerosol characterization and delivery technologies.

Contact Dr. Dennis

Francis Green, MD, PhD

Chief Scientific Officer & Co-Founder

Francis is a co-founder and inventor of the SAMi technology. He is a respiratory pathologist and has expertise in the human and animal models of asthma and inhalation toxicology. His innovative mindset is at the heart of SolAeroMed’s technology and development strategy.

Gareth Lewis, MBT, MBA, CMA

Chief Financial Officer

Gareth brings expertise in financial management, strategic planning, financial performance, risk management and business case development. Gareth has a varied educational background that includes a Bachelor of Science degree with Honours from the University of Toronto and combined Master of Business Administration / Master of Biomedical Technology degrees from the University of Calgary. He has financial management expertise supported by a qualification as a Certified Management Accountant.

Richard Leigh, MD, PhD

Clinical Lead

Richard is a clinical respirologist-scientist and the GSK-CIHR Professor of Inflammatory Lung Disease in the Division of Respiratory Medicine at the University of Calgary. He is also the director of the Respiratory Clinical Trials Unit at the University of Calgary.

Cora Pieron, PhD, MSc, CSLT

Drug Delivery

Cora provides support for drug delivery device design and delivery technologies and maintains our cGMP drug aerosol test laboratory.  Cora also provides general operational, scientific, and research and development support.